Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter
Diagnostics Oncology, Digital and computational pathology, Technology and innovation

With a Little Help from AI

Credit: Max Zhao.

When it comes to artificial intelligence (AI) diagnostics, there are discrepancies between labs – with smaller standalone labs often yielding too little data to train highly accurate AI models. For leukemia and lymphoma diagnostics, multiparameter flow cytometry (MFC) is a vital tool in the pathologists’ toolbox; however, protocols are subject to change depending on individual labs’ diagnostic workflows and available cytometers. Could the two methods help each other out?

A group of researchers at the University of Bonn have combined transfer learning (a machine learning technique) with MFC to improve the robustness of AI in leukemia and lymphoma diagnostics (1). “The gold standard is diagnosis by hematologists, which can also take into account results of additional tests,” said Peter Krawitz of the Institute for Genomic Statistics and Bioinformatics at the University Hospital Bonn (2). “The point of using AI is not to replace physicians, but to make the best use of the information contained in the data.”

The workflow takes AI models that are trained on a specific MFC panel and extends them to multiple MFC panels and data sizes. The team found that this extension improved AI performance and achieved high accuracy for multi-label classification of hematological malignancies across datasets. The workflow also enabled models to quickly adapt to changes in the data – making it accessible for a variety of routine diagnostic settings. Though the model’s diagnosis is only a suggestion and requires physician verification, lead author Nanditha Mallesh noted that “AI takes full advantage of the data and increases the speed and objectivity of diagnoses (2).”

The researchers have made the data and software freely accessible – and their collaborators at res mechanica GmbH have created a web service to make AI more accessible to users who lack bioinformatics expertise. Hannes Lüling, founder and CEO of res mechanica GmbH, stated, “We want to enable the exchange of anonymized flow cytometry data between laboratories and in this way create the conditions for even higher quality in diagnostics.”

Webinar

Sponsored by Thermo Fisher Scientific

Connecting Patients Everywhere to Precision Oncology

Register today for our webinar with Thermo Fisher Scientific on May 26, 2022, and examine why the timely availability of clinically relevant biomarker data is crucial for oncology patients’ therapy management. You will also learn about an NGS test for identifying precision oncology biomarkers that is based on an end-to-end NGS workflow solution.

Get on the guest list

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. N Mallesh et al., Patterns, 2, 100351 (2021).
  2. University of Bonn (2021). Available at: https://bit.ly/3BLQOWw.
About the Author
Liv Gaskill

During my undergraduate degree in psychology and Master’s in neuroimaging for clinical and cognitive neuroscience, I realized the tasks my classmates found tedious – writing essays, editing, proofreading – were the ones that gave me the greatest satisfaction. I quickly gathered that rambling on about science in the bar wasn’t exactly riveting for my non-scientist friends, so my thoughts turned to a career in science writing. At Texere, I get to craft science into stories, interact with international experts, and engage with readers who love science just as much as I do.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register